Osborne Clarke advises syndicate of investors on Epitopea's US$14 million financing to advance cancer immunotherapeutics
International law firm Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI...
Published on
10/10/2022
Read time
1m